BioTrinity 2025 will be OBN’s flagship two-day conference, taking place in its 19th year. The event will feature presentations from R&D companies at Series A stage across 14 therapy areas, offering insights into emerging innovations. With a focus on business growth, the conference will include a business & investment track, networking events, private partnering meetings, and an academic poster presentation.
With an expected audience of 900 delegates, it will bring together early-stage life sciences companies, investors, pharma professionals, and academics from across the globe. Sponsorship, session hosting, and delegation opportunities are available.
